120 related articles for article (PubMed ID: 15609312)
1. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.
Rakha EA; Armour JA; Pinder SE; Paish CE; Ellis IO
Int J Cancer; 2005 May; 114(5):720-9. PubMed ID: 15609312
[TBL] [Abstract][Full Text] [Related]
2. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
Rakha EA; Pinder SE; Paish CE; Ellis IO
Br J Cancer; 2004 Oct; 91(8):1591-6. PubMed ID: 15354217
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Green AR; Krivinskas S; Young P; Rakha EA; Paish EC; Powe DG; Ellis IO
Breast Cancer Res Treat; 2009 Jan; 113(1):59-66. PubMed ID: 18213475
[TBL] [Abstract][Full Text] [Related]
4. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
[TBL] [Abstract][Full Text] [Related]
5. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
6. Covariation of copy number located at 16q22.1: new evidence in mammary ductal carcinoma.
Sun Q; Yang YM; Yu SH; Zhang YX; He XG; Sun SS; Liang XS; Pang D
Oncol Rep; 2012 Dec; 28(6):2156-62. PubMed ID: 23007606
[TBL] [Abstract][Full Text] [Related]
7. CTCF gene mutations in invasive ductal breast cancer.
Aulmann S; Bläker H; Penzel R; Rieker RJ; Otto HF; Sinn HP
Breast Cancer Res Treat; 2003 Aug; 80(3):347-52. PubMed ID: 14503807
[TBL] [Abstract][Full Text] [Related]
8. High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.
Frengen E; Rocca-Serra P; Shaposhnikov S; Taine L; Thorsen J; Bepoldin C; Krekling M; Lafon D; Aas KK; El Monéim AA; Johansen H; Longy M; Prydz H; Dorion-Bonnet F
Genomics; 2000 Dec; 70(3):273-85. PubMed ID: 11161777
[TBL] [Abstract][Full Text] [Related]
9. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
10. Loss of chromosome 16q in lobular carcinoma in situ.
Etzell JE; Devries S; Chew K; Florendo C; Molinaro A; Ljung BM; Waldman FM
Hum Pathol; 2001 Mar; 32(3):292-6. PubMed ID: 11274638
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx G; Cleton-Jansen AM; Nollet F; de Leeuw WJ; van de Vijver M; Cornelisse C; van Roy F
EMBO J; 1995 Dec; 14(24):6107-15. PubMed ID: 8557030
[TBL] [Abstract][Full Text] [Related]
13. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
14. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
15. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
Berx G; Cleton-Jansen AM; Strumane K; de Leeuw WJ; Nollet F; van Roy F; Cornelisse C
Oncogene; 1996 Nov; 13(9):1919-25. PubMed ID: 8934538
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene.
Cheng CW; Wu PE; Yu JC; Huang CS; Yue CT; Wu CW; Shen CY
Oncogene; 2001 Jun; 20(29):3814-23. PubMed ID: 11439345
[TBL] [Abstract][Full Text] [Related]
18. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
20. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
